Planning Trade-offs for SABR in Patients With 4 to 10 Metastases: A Substudy of the SABR-COMET-10 Randomized Trial

Samaher Ashram,Houda Bahig,Aisling Barry,Denise Blanchette, Anders Celinksi,Peter Chung,Johnson Darko,David Donath,Robert Doucet, Abigail Erickson,Meredith Giuliani,Darin Gopaul,Scott Hipwell,Joanna Javor,Joda Kuk,Patricia Lindsay,Barbara Millman,Michael Oliver, Andrew Pearce, Catherine Russell

International Journal of Radiation Oncology*Biology*Physics（2022）

引用 6|浏览16

暂无评分

摘要

SABR planning for patients with 4-10 metastases was achievable without dosimetric compromise in the large majority of patients. Nodal and spinal targets were most likely to lead to compromise of target coverage or OAR constraints. Further research is needed to determine how to best balance these trade-offs.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要